statistiche ricercatore

Continente	#
NA - Nord America	1.266
EU - Europa	762
AS - Asia	539
SA - Sud America	43
AF - Africa	14
OC - Oceania	3
Continente sconosciuto - Info sul continente non disponibili	2
Totale	2.629

Nazione	#
US - Stati Uniti d'America	1.252
RU - Federazione Russa	254
PL - Polonia	202
CN - Cina	152
SG - Singapore	142
HK - Hong Kong	67
IT - Italia	63
IE - Irlanda	61
VN - Vietnam	52
SE - Svezia	48
KR - Corea	45
BR - Brasile	35
IN - India	33
GB - Regno Unito	26
DE - Germania	24
FR - Francia	22
FI - Finlandia	21
CA - Canada	12
BE - Belgio	10
ID - Indonesia	10
JO - Giordania	10
UA - Ucraina	9
CZ - Repubblica Ceca	7
IQ - Iraq	7
ES - Italia	6
AR - Argentina	3
AU - Australia	3
JP - Giappone	3
MY - Malesia	3
NG - Nigeria	3
TR - Turchia	3
BD - Bangladesh	2
CI - Costa d'Avorio	2
KE - Kenya	2
MX - Messico	2
NL - Olanda	2
PK - Pakistan	2
PT - Portogallo	2
SA - Arabia Saudita	2
ZA - Sudafrica	2
AL - Albania	1
BJ - Benin	1
CG - Congo	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
EG - Egitto	1
EU - Europa	1
HU - Ungheria	1
IL - Israele	1
KZ - Kazakistan	1
LT - Lituania	1
MA - Marocco	1
PE - Perù	1
PH - Filippine	1
PY - Paraguay	1
QA - Qatar	1
RO - Romania	1
TH - Thailandia	1
TN - Tunisia	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.629

Nome	#
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial	271
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data	258
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis	253
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?	236
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study	213
HepaDisk – A new quality of life questionnaire for HCV patients	205
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel	189
Real life experiences in HCV management in 2018	186
From current status to optimization of HCV treatment: Recommendations from an expert panel	185
Black-holes, topological strings and large N phase transitions	173
Metabolic disorders across hepatocellular carcinoma in Italy	171
Non-Commutative topologically massive gauge theory	162
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study	151
Totale	2.653

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	28	0	0	0	0	0	0	0	0	0	0	12	16
2021/2022	93	5	3	7	2	2	11	4	6	5	6	15	27
2022/2023	233	25	55	20	5	13	36	34	10	18	10	4	3
2023/2024	129	5	11	17	9	12	29	4	25	1	0	9	7
2024/2025	799	32	72	45	114	222	161	10	34	21	13	31	44
2025/2026	719	89	114	81	65	80	32	106	19	40	69	24	0
Totale													2.653